Cited by 394Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

The DOI matches its Crossref record; 162 of the 166 references it cites were found in a registry or an index.

The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Madras, Bertha K., Miller, Gregory M., Fischman, Alan J.·2005·Biological Psychiatry

DOI 10.1016/j.biopsych.2004.10.011

Open this paper in CoChat — free account

Abstract

The high incidence of attention-deficit/hyperactivity disorder (ADHD) and escalating use of ADHD medications present a compelling case for clarifying the pathophysiology of, and developing laboratory or radiologic tests for, ADHD. Currently, the majority of specific genes implicated in ADHD encode components of catecholamine signaling systems. Of these, the dopamine transporter (DAT) is a principal target of the most widely used antihyperactivity medications (amphetamine and methylphenidate); the DAT gene is associated with ADHD, and some studies have detected abnormal levels of the DAT in brain striatum of ADHD subjects. Medications for ADHD interfere with dopamine transport by brain-region- and drug-specific mechanisms, indirectly activating dopamine- and possibly norepinephrine-receptor subtypes that are implicated in enhancing attention and experiential salience. The most commonly used DAT-selective ADHD medications raise extracellular dopamine levels in DAT-rich brain regions. In brain regions expressing both the DAT and the norepinephrine transporter (NET), the relative contributions of dopamine and norepinephrine to ADHD pathophysiology and therapeutic response are obfuscated by the capacity of the NET to clear dopamine as well as norepinephrine. Thus, ADHD medications targeting DAT or NET might disperse dopamine widely and consign dopamine storage and release to regulation by noradrenergic, as well as dopaminergic neurons.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2004.10.011

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Association of attention-deficit disorder and the dopamine transporter gene.
Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & LEVENTHAL, B. L. (1995) · PubMed · Cited by 995
Trace amines: Identification of a family of mammalian G protein-coupled receptors
Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Self-citation
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651

Show all 166 references

Research works printed but not linked: 5

Barkley, 2001, vol. 9
Brown, 2001, Regulation of the vesicular monoamine transporter-2, J Pharmacol Exp Ther, 296, 762
DiMaio, 2003, Dopamine genes and attention-deficit hyperactivity disorder, J Psychiatry Neurosci, 28, 27
Galili-Weisstub, 2003, Attention deficit and hyperactivity disorder, Isr J Psychiatry Relat Sci, 40, 57
Goulet, 2000, Chronic methylphenidate treatment suppresses activity in more active juvenile monkeys and induces sleep disturbances, Soc Neurosci Abstracts, 26, 2177

Sorted by citations

Items 101–200 of 394

Attention-Deficit/Hyperactivity Disorder in Older Adults: Prevalence and Possible Connections to Mild Cognitive Impairment
Ivanchak, N., Fletcher, K., & Jicha, G. A. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0305-8 · Cited by 54
Neural response to working memory load varies by dopamine transporter genotype in children
Stollstorff, M., Foss‐Feig, J. H., Cook, E. H., Stein, M. A., Gaillard, W. D., & Vaidya, C. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.104 · Cited by 58
Adaptations of Presynaptic Dopamine Terminals Induced by Psychostimulant Self-Administration
Siciliano, C. A., Calipari, E. S., Ferris, M. J., & Jones, S. R. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5002705 · Cited by 57
Dopaminergic genotype biases spatial attention in healthy children
Bellgrove, M. A., Chambers, C., Johnson, K. A., Dáibhis, A., Daly, M., Hawi, Z., Lambert, D., Gill, M., & Robertson, I. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002022 · Cited by 52
Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders
Wooters, T. E., Dwoskin, L. P., & Bardo, M. T. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0445-9 · Cited by 51
Immunologic and neurodevelopmental susceptibilities of autism
Pessah, I. N., Seegal, R. F., Lein, P. J., LaSalle, J., Yee, B. K., Van De Water, J., & Berman, R. F. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.02.006 · Cited by 51
ADHD pharmacogenetics across the life cycle: New findings and perspectives
Bruxel, E. M., Akutagava-Martins, G. C., Salatino-Oliveira, A., Contini, V., Kieling, C., Hutz, M., & Rohde, L. (2014) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32240 · Cited by 44
Functional Genomics of Attention-Deficit/Hyperactivity Disorder (ADHD) Risk Alleles on Dopamine Transporter Binding in ADHD and Healthy Control Subjects
Spencer, T. J., Biederman, J., Faraone, S. V., Madras, B. K., Bonab, A. A., Dougherty, D. D., Batchelder, H., Clarke, A., & Fischman, A. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.010 · Cited by 54
Self-citation
Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD
Mick, E. O., Biederman, J., Spencer, T. J., Faraone, S. V., & Sklar, P. B. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30376 · Cited by 51
Acute physical exercise improves shifting in adolescents at school: evidence for a dopaminergic contribution
Berse, T., Rolfes, K., Barenberg, J., Dutke, S., Kuhlenbäumer, G., Völker, K., Winter, B., Wittig, M., & Knecht, S. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00196 · Cited by 51
Methylphenidate
Devos, D., Moreau, C., Delval, A., Dujardin, K., Defebvre, L., & Bordet, R. (2012) · CNS Drugs · doi:10.1007/s40263-012-0017-y · Cited by 47
Association of dopamine transporter genotype with disruptive behavior disorders in an eight‐year longitudinal study of children and adolescents
Lee, S. S., Lahey, B. B., Waldman, I. D., Hulle, C. A. V., Rathouz, P. J., Pelham, W. E., Loney, J., & Cook, E. H. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30447 · Cited by 47
Daily methylphenidate and atomoxetine treatment impacts on clock gene protein expression in the mouse brain
Baird, A. L., Coogan, A. N., Kaufling, J., Barrot, M., & Thome, J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.03.038 · Cited by 46
Pharmacotherapy in pediatric obesity: current evidence and landscape
Singhal, V., Sella, A. C., & Malhotra, S. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000587 · Cited by 51
Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele
Krause, J., Dresel, S. H. J., Krause, K., la Fougère, C., Zill, P., & Ackenheil, M. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500518444 · Cited by 47
Moment-to-moment dynamics of ADHD behaviour in South African children
Aase, H., Meyer, A., & Sagvolden, T. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-11 · Cited by 50
Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: Interhemispheric effects
Yano, M., Beverley, J. A., & Steiner, H. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.017 · Cited by 46
Evolution of Neurologic Features in Williams Syndrome
Gagliardi, C., Martelli, S., Burt, D. M., & Borgatti, R. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.01.001 · Cited by 45
Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype
Sengupta, S. M., Grizenko, N., Thakur, G. A., Bellingham, J., DeGuzman, R., ROBINSON, S. O., Ter-Stepanian, M., Poloskia, A., Shaheen, S. ‐., Fortier, M., et al. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110073 · Cited by 46
Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder
Staller, J. A., & Faraone, S. V. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.4.351 · Cited by 44
Species Differences in Somatodendritic Dopamine Transmission Determine D2-Autoreceptor-Mediated Inhibition of Ventral Tegmental Area Neuron Firing
Courtney, N. A., Mamaligas, A. A., & Ford, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2745-12.2012 · Cited by 40
Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3)
Mick, E., Kim, J.-W., Biederman, J., Wozniak, J., Wilens, T., Spencer, T., Smoller, J. W., & Faraone, S. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30745 · Cited by 44
Effect of Dopamine Transporter Genotype on Intrinsic Functional Connectivity Depends on Cognitive State
Gordon, E. M., Stollstorff, M., Devaney, J. M., Bean, S. E., & Vaidya, C. J. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr305 · Cited by 44
Altered Corticostriatal Neurotransmission and Modulation in Dopamine Transporter Knock-Down Mice
Wu, N., Cepeda, C., Zhuang, X., & Levine, M. S. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00971.2006 · Cited by 43
Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD
Advokat, C. D. (2007) · Journal of Attention Disorders · doi:10.1177/1087054706295605 · Cited by 44
Early stress and chronic methylphenidate cross‐sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens
Jezierski, G., Zehle, S., Bock, J., Braun, K., & Gruss, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04927.x · Cited by 41
Distinct neurochemical influences on fMRI response polarity in the striatum
Cerri, D. H., Albaugh, D. L., Walton, L. R., Katz, B. M., Wang, T.-W. W., Chao, T.-H. H., Zhang, W., Nonneman, R. J., Jiang, J., Lee, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46088-z · Cited by 39
Dopamine transporter genotype predicts implicit sequence learning
Simon, J. R., Stollstorff, M., Westbay, L. C., Vaidya, C. J., Howard, J. H., & Howard, D. V. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.043 · Cited by 41
Amphetamine potency varies with dopamine uptake rate across striatal subregions
Siciliano, C. A., Calipari, E. S., & Jones, S. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12808 · Cited by 40
Cortical thickness differences in the prefrontal cortex in children and adolescents with ADHD in relation to dopamine transporter (DAT1) genotype
Fernández‐Jaén, A., López‐Martín, S., Albert, J., Fernández-Mayoralas, D. M., Fernández‐Perrone, A. L., de la Peña, M. J., Calleja‐Pérez, B., Rodríguez, M. R., López-Arribas, S., & Jareño, N. M. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.07.005 · Cited by 43
An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder
Frölich, J., Banaschewski, T., Döpfner, M., & Görtz‐Dorten, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.922542 · Cited by 40
Individual Differences in Dopamine Are Associated with Reward Discounting in Clinical Groups But Not in Healthy Adults
Castrellon, J. J., Seaman, K. L., Crawford, J. L., Young, J. S., Smith, C. T., Dang, L. C., Hsu, M., Cowan, R. L., Zald, D. H., & Samanez-Larkin, G. R. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1984-18.2018 · Cited by 39
Human Induced Pluripotent Stem Cell‐Derived Neural Progenitor Cells Produce Distinct Neural 3D In Vitro Models Depending on Alginate/Gellan Gum/Laminin Hydrogel Blend Properties
Kapr, J., Petersilie, L., Distler, T., Lauria, I., Bendt, F., Sauter, C. M., Boccaccini, A. R., Rose, C. R., & Fritsche, E. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100131 · Cited by 40
Effects of acute and chronic methylphenidate on delay discounting
Slezak, J. M., & Anderson, K. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.05.027 · Cited by 38
Attention-deficit hyperactivity disorder (ADHD) as a pyridoxine-dependent condition: Urinary diagnostic biomarkers
Dolina, S., Margalit, D., Malitsky, S., & Rabinkov, A. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.11.018 · Cited by 38
Norepinephrine system at the interface of attention and reward
Zhang, Y., Chen, Y., Xin, Y., Peng, B., & Liu, S. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110751 · Cited by 38
A Developmental Perspective on Attention-Deficit/Hyperactivity Disorder (ADHD)
Campbell, S. B. G., Halperin, J. M., & Sonuga-Barke, E. J. S. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9608-3_22 · Cited by 39
Brain apoptosis signaling pathways are regulated by methylphenidate treatment in young and adult rats
Réus, G. Z., Scaini, G., Jeremias, G. C., Furlanetto, C. B., Morais, M. O. S., Mello-Santos, L. M., Quevedo, J., & Streck, E. L. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.010 · Cited by 37
Mind–Body Therapy for Children with Attention-Deficit/Hyperactivity Disorder
Herbert, A., & Esparham, A. E. (2017) · Children · doi:10.3390/children4050031 · Cited by 44
A promoter polymorphism (−839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children
Genro, J. P., Zeni, C., Polanczyk, G. V., Roman, T., Rohde, L. A., & Hutz, M. H. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30428 · Cited by 36
Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze
Kurzina, N. P., Aristova, I., Volnova, A. B., & Gainetdinov, R. R. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112642 · Cited by 38
Alterations in DRH and DRL performance in rats developmentally exposed to an environmental PCB mixture
Sable, H. J. K., Powers, B. E., Wang, V. C., Widholm, J. J., & Schantz, S. L. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.06.005 · Cited by 35
Central Dopaminergic System and Its Implications in Stress-Mediated Neurological Disorders and Gastric Ulcers: Short Review
Rasheed, N., & Alghasham, A. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/182671 · Cited by 38
Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats
Gomes, K. M., Inácio, C. G., Valvassori, S. S., Réus, G. Z., Boeck, C. R., Dal-Pizzol, F., & Quevedo, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.060 · Cited by 34
YY162 prevents ADHD-like behavioral side effects and cytotoxicity induced by Aroclor1254 via interactive signaling between antioxidant potential, BDNF/TrkB, DAT and NET
Nam, Y., Shin, E., Shin, S. W., Lim, Y. K., Jung, J. H., Lee, J. H., Ha, J. R., Chae, J. S., Ko, S. K., Jeong, J. H., et al. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.046 · Cited by 35
Methylphenidate effects in the young brain: friend or foe?
Loureiro‐Vieira, S., Costa, V. M., Bastos, M. D. L., Carvalho, F. D., & Capela, J. P. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.04.002 · Cited by 37
Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder
Baykal, S., Albayrak, Y., Durankuş, F., Güzel, S., Abbak, Ö., Potas, N., Beyazyüz, M., Karabekiroğlu, K., & Donma, M. M. (2019) · Neurological Sciences · doi:10.1007/s10072-018-3692-8 · Cited by 34
No Tryptophan, Tyrosine and Phenylalanine Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder
Bergwerff, C. E., Luman, M., Blom, H., & Oosterlaan, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151100 · Cited by 34
Neurotoxicity induced by the pyrethroid lambda-cyhalothrin: Alterations in monoaminergic systems and dopaminergic and serotoninergic pathways in the rat brain
López-Torres, B., Arés, I., Martínez, M., Maximiliano, J.-E., Martínez‐Larrañaga, M., Anadón, A., & Martínez, M. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113434 · Cited by 34
Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits
Minzenberg, M. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0128-7 · Cited by 36
Comprehensive Phenotype/Genotype Analyses of the Norepinephrine Transporter Gene (SLC6A2) in ADHD: Relation to Maternal Smoking during Pregnancy
Thakur, G. A., Sengupta, S. M., Grizenko, N., Choudhry, Z., & Joober, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049616 · Cited by 36
Circadian Clocks in the Regulation of Neurotransmitter Systems
Kiehn, J., Faltraco, F., Palm, D., Thome, J., & Oster, H. (2019) · Pharmacopsychiatry · doi:10.1055/a-1027-7055 · Cited by 36
The Association of a Novel Haplotype in the Dopamine Transporter with Preschool Age Posttraumatic Stress Disorder
Drury, S. S., Brett, Z. H., Henry, C., & Scheeringa, M. S. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0072 · Cited by 33
Family and Genetic Association Studies of Bipolar Disorder in Children
Mick, E. O., & Faraone, S. V. (2009) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2008.11.008 · Cited by 35
Effects of methylphenidate on reinforcement learning depend on working memory capacity
Kandroodi, M. R., Cook, J. L., Swart, J. C., Froböse, M. I., Geurts, D. E. M., Vahabie, A., Ahmadabadi, M. N., Cools, R., & den Ouden, H. E. M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05974-w · Cited by 39
Gait and attentional performance in freezers under methylphenidate
Delval, A., Moreau, C., Bleuse, S., Guehl, D., Bestaven, E., Guillaud, É., Dujardin, K., Defebvre, L., & Devos, D. (2014) · Gait & Posture · doi:10.1016/j.gaitpost.2014.10.022 · Cited by 32
A murine model of hyperdopaminergic state displays altered respiratory control
Vincent, S. G., Waddell, A., Caron, M. G., Walker, J. K. L., & Fisher, J. T. (2007) · The FASEB Journal · doi:10.1096/fj.06-7248com · Cited by 32
Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls
Shook, D., Brady, C., Lee, P. S., Kenealy, L., Murphy, E. R., Gaillard, W. D., VanMeter, J. W., Cook, E. H., Stein, M., & Vaidya, C. J. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31132 · Cited by 31
The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder
Ashton, H., Gallagher, P., & Moore, B. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106061710 · Cited by 31
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor
Verrico, C. D., Lynch, L. J., Fahey, M. A., Fryer, A.-K., Miller, G. M., & Madras, B. K. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083639 · Cited by 28
Self-citation
The effects of rearing environment and chronic methylphenidate administration on behavior and dopamine receptors in adolescent rats
Gill, K. E., Beveridge, T. J. R., Smith, H. R., & Porrino, L. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.021 · Cited by 30
Stimulants for the Control of Hedonic Appetite
Poulton, A. S., Hibbert, E., Champion, B. L., & Nanan, R. K. H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00105 · Cited by 31
EphB1 null mice exhibit neuronal loss in substantia nigra pars reticulata and spontaneous locomotor hyperactivity
Richards, A. B., Scheel, T. A., Wang, K., Henkemeyer, M. J., & Kromer, L. F. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05523.x · Cited by 30
The Neurobiology of Attention-Deficit/Hyperactivity Disorder
Fischman, A. J., & Madras, B. K. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.035 · Cited by 30
Self-citation
A Dopamine Receptor (DRD2) but Not Dopamine Transporter (DAT1) Gene Polymorphism is Associated with Neurocognitive Development of Mexican Preschool Children with Lead Exposure
Kordas, K., Ettinger, A. S., Bellinger, D. C., Schnaas, L., Téllez‐Rojo, M. M., Hernández‐Ávila, M., Hu, H., & Wright, R. O. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.03.043 · Cited by 28
The basal ganglia in reward and decision making
Doll, B. B., & Frank, M. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374620-7.00019-4 · Cited by 31
Nature and nurture? A review of the literature on childhood maltreatment and genetic factors in the pathogenesis of borderline personality disorder
Wilson, N., Robb, E., Gajwani, R., & Minnis, H. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.025 · Cited by 38
Differential Influence of Dopamine Transport Rate on the Potencies of Cocaine, Amphetamine, and Methylphenidate
Calipari, E. S., Ferris, M. J., Siciliano, C. A., & Jones, S. R. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500262x · Cited by 29
The Lignan (−)-Hinokinin Displays Modulatory Effects on Human Monoamine and GABA Transporter Activities
Timple, J. M. V., Magalhães, L. G., Rezende, K. C. S., Pereira, A. C., Cunha, W. R., Silva, M. L. A. E., Mortensen, O. V., & Fontana, A. C. K. (2013) · Journal of Natural Products · doi:10.1021/np400452n · Cited by 29
Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children
Mick, E. O., Wozniak, J. R., Wilens, T. E., Biederman, J., & Faraone, S. V. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-2 · Cited by 29
Regional differences in cerebral perfusion associated with the α-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder
Kim, B., Kim, J.-W., Kang, H., Cho, S.-C., Shin, M., Yoo, H., Hong, S.-B., & Lee, D. S. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.090168 · Cited by 29
Evidence of Brain Dysfunction in Attention Deficit-Hyperactivity Disorder: a Controlled Study with Proton Magnetic Resonance Spectroscopy
Fayed, N. M., Modrego, P. J., Castillo, J., & Dávila, J. (2007) · Academic Radiology · doi:10.1016/j.acra.2007.05.017 · Cited by 29
The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD
Tenenbaum, Y. S., Weizman, A., & Rehavi, M. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.04.007 · Cited by 28
DAT1 and DRD4 genes involved in key dimensions of adult ADHD
Hasler, R., Salzmann, A., Bolzan, T., Zimmermann, J., Baud, P., Giannakopoulos, P., & Perroud, N. A. (2015) · Neurological Sciences · doi:10.1007/s10072-014-2051-7 · Cited by 29
Blockade of adenosine A1 receptors prevents methylphenidate-induced impairment of object recognition task in adult mice
Mioranzza, S., da Costa, M. S., Botton, P. H. S., Ardais, A. P., Matte, V. L., Espinosa, J., Souza, D. O., & Porciúncula, L. O. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.022 · Cited by 28
Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuroimaging?
Plomp, E., van Engeland, H., & Durston, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.024 · Cited by 28
Human Genetics and Pharmacology of Neurotransmitter Transporters
Lin, Z., & Madras, B. K. (2006) · Handbook of experimental pharmacology · doi:10.1007/3-540-29784-7_16 · Cited by 29
Self-citation
Loss of striatal cannabinoid CB1 receptor function in attention‐deficit / hyperactivity disorder mice with point‐mutation of the dopamine transporter
Castelli, M., Federici, M., Rossi, S., Chiara, V. D., Napolitano, F., Studer, V., Motta, C., Sacchetti, L., Romano, R., Musella, A., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07876.x · Cited by 28
Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder
Kim, B.-N., Kim, J.-W., Hong, S.-B., Cho, S.-C., Shin, M., & Yoo, H. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-57 · Cited by 28
Mini Nutritional Assessment May Identify a Dual Pattern of Perturbed Plasma Amino Acids in Patients with Alzheimer’s Disease: A Window to Metabolic and Physical Rehabilitation?
Aquilani, R., Costa, A. C., Maestri, R., Ramusino, M. C., Pierobon, A., Dossena, M., Solerte, S. B., Condino, A. M., Torlaschi, V., Bini, P., et al. (2020) · Nutrients · doi:10.3390/nu12061845 · Cited by 27
Enlarged striatal volume in adults with ADHD carrying the 9-6 haplotype of the dopamine transporter gene DAT1
Onnink, A. M. H., Franke, B., van Hulzen, K. J. E., Zwiers, M. P., Mostert, J. C., Schene, A. H., Heslenfeld, D. J., Oosterlaan, J., Hoekstra, P. J., Hartman, C. A., et al. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1521-x · Cited by 28
Dopaminergic and Noradrenergic Gene Polymorphisms and Response to Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder: Is There an Interaction?
Hong, S.-B., Kim, J.-W., Cho, S.-C., Shin, M., Kim, B.-N., & Yoo, H. (2012) · Journal of child and adolescent psychopharmacology · doi:10.1089/cap.2011.0076 · Cited by 26
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26
Association between trypotphan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants
Manor, I., Laiba, E., Eisenberg, J., Meidad, S., Lerer, E., Israel, S., Gritsenko, I., Tyano, S., Faraone, S. V., & Ebstein, R. P. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30702 · Cited by 27
The prevalence of attention-deficit/hyperactivity disorder among school-aged children in Benin City, Nigeria
Ofovwe, C. E., Ofovwe, G. E., & Meyer, A. (2006) · Journal of Child and Adolescent Mental Health · doi:10.2989/17280580609486611 · Cited by 26
Nicotine Reduces Antipsychotic-Induced Orofacial Dyskinesia in Rats
Bordia, T., McIntosh, J. M., & Quik, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189100 · Cited by 25
Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder
Hiraide, S., Ueno, K.-I., Yamaguchi, T., Matsumoto, M., Yanagawa, Y., Yoshioka, M., & Togashi, H. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.009 · Cited by 24
Placing Neuroanatomical Models of Executive Function in a Developmental Context
Brocki, K. C., Fan, J., & Fossella, J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.025 · Cited by 26
Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder
Koevoet, D., Deschamps, P. K. H., & Kenemans, J. L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1078586 · Cited by 28
Developmental pathways to attention-deficit/hyperactivity disorder and disruptive behavior disorders: Investigating the impact of the stress response on executive functioning
Johnson, A. C. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.12.001 · Cited by 27
Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
Popovic, B., Bhattacharya, P., & Sivaswamy, L. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080353 · Cited by 24
The effects of a Self-Alert Training (SAT) program in adults with ADHD
Salomone, S., Fleming, G. R., Shanahan, J. M., Castorina, M., Bramham, J., O’Connell, R. G., & Robertson, I. H. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00045 · Cited by 25
Strengths and limitations of genetic models of ADHD
Gainetdinov, R. R. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0021-3 · Cited by 24
Antipsychotic‐induced gene regulation in multiple brain regions
Girgenti, M. J., Nisenbaum, L. K., Bymaster, F. P., Terwilliger, R. Z., Duman, R. S., & Newton, S. S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06585.x · Cited by 25
Intracortical motor inhibition and facilitation in adults with attention deficit/hyperactivity disorder
Hoeppner, J., Neumeyer, M., Wandschneider, R., Herpertz, S. C., Gierow, W., Haessler, F., & Buchmann, J. A. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0091-y · Cited by 25
Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research
Elsayed, N. A., Yamamoto, K. M., & Froehlich, T. E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00702-y · Cited by 23
Deficiency of transmembrane AMPA receptor regulatory protein γ-8 leads to attention-deficit hyperactivity disorder-like behavior in mice
Bai, W., 河北医科大学中西医结合研究所中药与中药药理教研室, 教., Luο, X., Jin, B., Zhu, K., Guo, W., Zhu, X., Qin, X., Yang, Z., Zhao, J.-J., et al. (2022) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.122 · Cited by 25
Prenatal Alcohol Exposure in Rodents As a Promising Model for the Study of ADHD Molecular Basis
Rojas-Mayorquín, A. E., Padilla-Velarde, E., & Ortuño‐Sahagún, D. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00565 · Cited by 24
Prediction of sleep side effects following methylphenidate treatment in ADHD youth
Yoo, J. H., Sharma, V., Kim, J. W., McMakin, D. L., Hong, S.-B., Zalesky, A., Kim, B.-N., & Ryan, N. D. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102030 · Cited by 23
Residential pyrethroid insecticide use, urinary 3-phenoxybenzoic acid levels, and attention-deficit/hyperactivity disorder-like symptoms in preschool-age children: The Environment and Development of Children study
Lee, W.-S., Lim, Y.-H., Kim, B.-N., Shin, C. H., Lee, Y. A., Kim, J. I., Hong, Y., & Kim, K. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109739 · Cited by 21

Authors: Madras, B. K., Miller, G. M., & Fischman, A. J.
Affiliations: Harvard University (US)
Massachusetts General Hospital (US)
Corresponding author: Madras, Bertha K.
ORCID: Madras, Bertha K.
Miller, Gregory M.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2005-06
Volume: 57
Issue: 11
Pages: 1397-1409
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2004.10.011
OpenAlex: W2011083427
Cited by: 393
References: 166
Citations by year: 2026: 10 · 2025: 20 · 2024: 9 · 2023: 13 · 2022: 11 · 2021: 12 · 2020: 18 · 2019: 10 · 2018: 11 · 2017: 11 · 2016: 14 · 2015: 15 · 2014: 23 · 2013: 16 · 2012: 27
FWCI: 4.54
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA 06303, R01DA011558, K05DA015305, DA15305, DA 11558)
National Center for Research Resources (RR00 168)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords: dopamine transporter, attention deficit hyperactivity disorder, ADHD pathophysiology, catecholamine signaling, norepinephrine transporter, amphetamine, methylphenidate, striatum, dopamine, norepinephrine, ADHD medication, genetic susceptibility
MeSH terms: Adaptation, Physiological, Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Diagnostic Imaging, Humans, Membrane Glycoproteins, Mutation, Nerve Tissue Proteins, Genetic Variation, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Vesicular Biogenic Amine Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks